SEC Form D · filed June 26, 2025
RedShift BioAnalytics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Thomas O'Lenic · Boxborough, MAExec · DirectorWouter Meuleman · Boxborough, MADirectorBryson Hollimon · Boxborough, MADirectorFrank Smith · Boxborough, MADirectorWilliam Cadogan · Boxborough, MADirectorBryson Hollimon · Boxborough, MADirectorFrank Smith · Boxborough, MADirectorThomas O'Lenic · Boxborough, MAExec · DirectorWilliam Cadogan · Boxborough, MADirectorWouter Meuleman · Boxborough, MADirectorSusan Holleran · Boxborough, MADirectorIgor S. Merk · Kaneohe, HIDirectorAlexander Silva · Kailua, HIDirectorSean Warnet · Waipahu, HIDirectorKoliah S. Ramirez · Wahiawa, HIExec · DirectorAlfred S. Paclib · Aiea, HIDirectorSusan Holleran · Boxborough, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗